Seventh Pandemic Vibrio cholerae O1 Sublineages, Central African Republic
Sebastien Breurec
1, Thierry Franck
12, Elisabeth Njamkepo, Jean-Robert Mbecko, Jean Rauzier, Hugues Sanke-Waïgana, Guyguy Kamwiziku, Renaud Piarroux, Marie-Laure Quilici
3, and François-Xavier Weill
3
Author affiliations: Institut Pasteur de la Guadeloupe, Les Abymes, France (S. Breurec); INSERM Centre d’Investigation Clinique 1424, Pointe-à-Pitre/Les Abymes, France (S. Breurec); Université des Antilles, Pointe-à-Pitre, France (S. Breurec); Institut Pasteur de Bangui, Bangui, Central African Republic (S. Breurec, T. Franck, J.-R. Mbecko); Institut Pasteur, Paris, France (E. Njamkepo, J. Rauzier, M.-L. Quilici, F.-X. Weill); Université de Kinshasa, Kinshasa, Democratic Republic of the Congo (G. Kamwiziku); Assistance Publique-Hôpitaux de Paris, Paris (R. Piarroux)
Main Article
Table 2
Alterations of the wbeT (formerly rfbT) gene in Vibrio cholerae El Tor isolates from the Central African Republic*
Alteration no. |
Alteration type |
Genetic alteration |
Protein consequence† |
7PET sublineage |
A03 |
Premature stop codon |
G133T |
G45-to-STOP |
T7 |
B01 |
Premature stop codon |
Deletion TGTAC (nt 24–28) |
Frameshift after N7; then STOP |
T10 |
C19 |
Amino acid substitution |
G674A |
C225Y |
T9 |
Main Article
Page created: December 01, 2020
Page updated: December 21, 2020
Page reviewed: December 21, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.